Medication
Ended Awarded
- Contract number
- 36C24622N0860
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $11,414
Award facts
- Contract value 100% obligated
- $11,413.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
Otsuka America Pharmaceutical Inc., a specialty pharmaceutical manufacturer headquartered in Rockville, Maryland, was awarded a delivery order on August 8, 2022, for medication supply to the Department of Veterans Affairs' Veterans Integrated Service Network 6. This firm-fixed price delivery order, valued at $11,413.72 with an ultimate completion date of August 31, 2022, represents a task order under the company's broader Blanket Purchase Agreement for pharmaceuticals issued through the General Services Administration's Pharmaceuticals and Drugs Federal Supply Schedule. The award carries no set-aside designation and utilizes Otsuka America's established contract vehicle to supply specialized pharmaceutical products to VA medical facilities.
This delivery order supports the Veterans Health Administration's mission of providing comprehensive healthcare to veterans, leveraging Otsuka America's significant federal contracting relationships with the VA across multiple Integrated Service Networks. The company maintains substantial indefinite delivery vehicles with the VA, including an $83.3 million Blanket Purchase Agreement for its signature product Jynarque (tolvaptan), used to treat autosomal dominant polycystic kidney disease and hyponatremia, and a $396 million Federal Supply Schedule contract for pharmaceuticals. The performance location in Potomac, Maryland, reflects the company's operational capacity to efficiently fulfill medication requirements for VA healthcare delivery across the nation.
Quick answers
Who was awarded contract 36C24622N0860?
36C24622N0860 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on August 8, 2022.
How much is contract 36C24622N0860 worth?
The government has obligated $11,414 on 36C24622N0860.
Is contract 36C24622N0860 an order under another contract?
Yes. 36C24622N0860 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24622N0860 competed?
The extent of competition for 36C24622N0860 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award